Latest news
Is Haemonetics (HAE) Undervalued As Q1 Earnings And Outlook Lift Optimism? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:37:53 GMTHaemonetics Q1 Earnings Call Highlights - MarketBeatMarketBeat · Sat, 08 Aug 2026 11:17:47 GMTHAE Q2 Deep Dive: Plasma and Interventional Growth Drive Outperformance, Margin Outlook Steady - StockStoryStockStory · Fri, 07 Aug 2026 09:19:06 GMTHaemonetics Corp (HAE) (Q1 2027) Earnings Call Highlights: Stron - GuruFocusGuruFocus · Thu, 06 Aug 2026 20:10:01 GMTCan New VASCADE MVP XL Data Strengthen Haemonetics' (HAE) Moat in Electrophysiology Adjacent Markets? - simplywall.stsimplywall.st · Tue, 04 Aug 2026 20:49:05 GMTHaemonetics (HAE) Is Up 5.1% After New VASCADE MVP XL Real-World Study Data Release – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 20:10:01 GMTHaemonetics study shows VASCADE MVP XL posts 1.2% vascular complications in 1,623 large-bore electrophysiology cases - BitgetBitget · Mon, 03 Aug 2026 12:24:59 GMT